Clinical Trials Directory

Trials / Sponsors / Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedI-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Neoplasm
Phase 22019-05-30
CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent
Phase 32018-11-27
CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Prostate Cancer
Phase 2 / Phase 32016-11-01
CompletedAn Open-label Extension Study of PSMA ADC 2301 in mCRPC
Prostate Cancer
Phase 22013-10-01
CompletedA Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Prostate Cancer
Phase 22012-09-01
CompletedExtended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
Prostate Cancer
Phase 12009-01-01
CompletedProstate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
Prostate Cancer
Phase 12008-10-01
CompletedSafety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
HIV Infections, Acquired Immune Deficiency Syndrome
Phase 22003-04-01